Publications by authors named "Bora Toklu"

Claim this Profile
E
Effect of Sex Difference on Discordance Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve.
Shunsuke Aoi, Bora Toklu, Naoki Misumida, Neil Patel, Wonkyoung Lee

Cardiovasc Revasc Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.
Sripal Bangalore, Bora Toklu, Neil Patel, Frederick Feit, Gregg W Stone

Circulation· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
Sripal Bangalore, Bora Toklu, Gregg W Stone

Am J Cardiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
Sripal Bangalore, Bora Toklu, Eugenia Gianos, Arthur Schwartzbard, Howard Weintraub

Am J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
Sripal Bangalore, Robert Fakheri, Simon Wandel, Bora Toklu, Jasmin Wandel

BMJ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete vs Culprit-Only Percutaneous Coronary Intervention in STEMI With Multivessel Disease: A Meta-analysis and Trial Sequential Analysis of Randomized Trials.
Kevin R Bainey, Robert C Welsh, Bora Toklu, Sripal Bangalore

Can J Cardiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relentless crumbling of the renin-angiotensin system (RAS)-blockade halo.
Franz H Messerli, Bora Toklu, Robert Fakheri, Sripal Bangalore

Ann Transl Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply-The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality.
Sripal Bangalore, Robert Fakheri, Bora Toklu, Franz H Messerli

Mayo Clin Proc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents: Insights from randomized trials.
Sripal Bangalore, Bora Toklu, Deepak L Bhatt

Int J Cardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.
Sripal Bangalore, Robert Fakheri, Bora Toklu, Franz H Messerli

BMJ· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
Sripal Bangalore, Robert Fakheri, Bora Toklu, Gbenga Ogedegbe, Howard Weintraub

Mayo Clin Proc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure lowering in patients with type 2 diabetes improves cardiovascular events including mortality, but more intensive lowering to systolic blood pressure less than 130 mm Hg is associated with further reduction in stroke and albuminuria without further reduction in cardiac events.
Bora Toklu, Sripal Bangalore

Evid Based Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.
Bora Toklu, Sripal Bangalore

Curr Treat Options Cardiovasc Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a meta-analysis and trial sequential analysis of randomized trials.
Sripal Bangalore, Bora Toklu, Jørn Wetterslev

Circ Cardiovasc Interv· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
Sripal Bangalore, Bora Toklu, Anupam Kotwal, Alexander Volodarskiy, Sahil Sharma

BMJ· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
Sripal Bangalore, Harikrishna Makani, Martha Radford, Kamia Thakur, Bora Toklu

Am J Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials.
Sripal Bangalore, Amita Singh, Bora Toklu, James J DiNicolantonio, Kevin Croce

Open Heart· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter regarding article, "Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?".
Sripal Bangalore, Bora Toklu, Frederick Feit

Circ Cardiovasc Interv· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
Sripal Bangalore, Bora Toklu, Frederick Feit

Circ Cardiovasc Interv· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choosing the right coronary stent in the modern era.
Bora Toklu, Sripal Bangalore

Curr Cardiol Rep· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
Sripal Bangalore, Bora Toklu, Nicholas Amoroso, Mario Fusaro, Sunil Kumar

BMJ· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization.
Louis H Miller, Bora Toklu, Judah Rauch, Jeffrey D Lorin, Iryna Lobach

J Invasive Cardiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis